2024
|
Invention
|
Compositions and methods for inducing immune response against epstein-barr viruses. e.ge.g., self... |
|
Invention
|
Compositions and methods for expression of egfr. The present disclosure relates to modified viral... |
|
Invention
|
System and method for cardiopulmonary bypass using hypobaric oxygenation.
A system for cardiopul... |
|
Invention
|
Compositions and methods for expression of il-1ra and il-18bp. The present disclosure relates to ... |
|
Invention
|
Methods for identification and selection of self-replicating rna molecules for biomedical applica... |
2023
|
Invention
|
Modified madariaga viruses, self-replicating rna constructs, and uses thereof. The present disclo... |
|
Invention
|
Modified madariaga viruses, self-replicating rna constructs, and uses thereof |
|
Invention
|
Modified western equine encephalitis viruses and uses thereof.
The present disclosure relates to... |
|
Invention
|
Modified western equine encephalitis viruses and uses thereof. The present disclosure relates to ... |
|
Invention
|
Modified western equine encephalitis viruses and uses thereof |
|
Invention
|
Compositions and methods for the prevention and treatment of rabies virus infection.
The present... |
|
Invention
|
Compositions and methods for the prevention and treatment of rabies virus infection. The present ... |
|
Invention
|
Compositions and methods for the prevention and treatment of rabies virus infection |
|
Invention
|
Methods for generating functional self-replicating rna molecules.
The present disclosure relates... |
|
Invention
|
Methods for generating functional self-replicating rna molecules. de novode novo functional srRNA... |
|
Invention
|
Methods for generating functional self-replicating rna molecules |
2022
|
Invention
|
Compositions and methods for expression of il-12 and il-1ra.
The present disclosure relates to t... |
|
Invention
|
Compositions and methods for inducing esr1, pi3k, her2, and her3 immune responses.
The present d... |
|
Invention
|
Methods of generating self-replicating rna molecules.
The present disclosure generally relates t... |
|
Invention
|
Compositions and methods for inducing esr1, pi3k, her2, and her3 immune responses. The present di... |
|
Invention
|
Methods of generating self-replicating rna molecules. The present disclosure generally relates to... |
|
Invention
|
Modified alphaviruses with heterologous nonstructural proteins.
The present disclosure relates t... |
|
Invention
|
Modified alphaviruses with heterologous nonstructural proteins. e.g.e.g., self-replicating RNAs),... |
|
Invention
|
Modified alphaviruses with heterologous nonstructural proteins. The present disclosure relates to... |
|
Invention
|
Modified eastern equine encephalitis viruses, self-replicating rna constructs, and uses thereof. ... |
|
Invention
|
Alphavirus vectors containing universal cloning adaptors.
The present disclosure relates to the ... |
|
Invention
|
Alphavirus vectors containing universal cloning adaptors. e.ge.g., self-replicating RNAs), pharma... |
2021
|
P/S
|
Pharmaceutical and biologic preparations for the treatment of cancer, autoimmune disorders and di... |
|
Invention
|
Compositions and methods for expression of il-12 and il-1ra. The present disclosure relates to th... |
|
Invention
|
Modified chikungunya viruses and sindbis viruses and uses thereof.
The present disclosure relate... |
|
Invention
|
Modified chikungunya viruses and sindbis viruses and uses thereof. The present disclosure relates... |